Robert Meguid, M.D., is the latest addition to the cardiothoracic surgery staff at the University of Colorado School of Medicine, adding a fresh perspective and an innovative approach.
Pleural and Lung Cancer
Video-Assisted Thoracoscopic Surgery
Board Certified in Surgery
Board Certified in Thoracic and Cardiac Surgery
Meguid joined the team as an assistant professor in summer 2012 after a residency at Johns Hopkins University School of Medicine and a fellowship in cardiothoracic surgery at the University of Washington.
His interest in lung transplants, along with malignant and benign lung diseases, became a good fit at the Colorado Medical Center, where more than 115 patients have undergone successful transplants in the last 20 years.
Dr. Meguid has received national recognition for several research articles in the field of thoracic surgery.
He joined a group of experienced surgeons, including John Mitchell, M.D., the chief of thoracic surgery at Colorado, and Michael Weyant, M.D. Together, the three also are handling patients with pleural mesothelioma, the cancer caused by exposure to asbestos.
We can help you or a loved one get in contact with Dr. Meguid and find the treatment that's best for you.Get Started Today
Before arriving, Meguid was part of research team at Johns Hopkins that conducted one of the largest studies ever done examining the correlation between volume of cases and survival rates at hospitals for both heart and lung transplants.
What he found in both instances was that survival rates were the highest at the centers that handled the most cases, and that hospitals that did the fewest transplants usually had the highest mortality rates. The results contradicted early government findings.
The Colorado School of Medicine has an experienced, multidisciplinary lung transplant team that includes pulmonologists, cardiothoracic surgeons, anesthesiologists, respiratory and physical therapists who work closely together to provide the best possible care for patients.
Meguid also brought his strong interests in minimally invasive thoracic surgical procedures (VATS), and a clinical interest in general surgery, esophagus and mediastinum diseases, chest wall tumors, reconstruction and end-stage lung diseases.
He came with research interests that included the identification of health care policies that lead to improved outcomes for surgical patients, nutrition metabolism, thoracic oncology and lung transplantation outcomes. He wrote several papers, including one that examined why surgical outcomes for lung cancer resections were improved at teaching hospitals in contrast to non-teaching hospitals.
In-hospital mortality is reduced for patients undergoing lung cancer resections at teaching hospitals, with results prominent at all but the highest volume institutions. Understanding and disseminating the processes of care associated with these settings may improve quality of care for lung cancer patients, and decrease patient bias against teaching hospitals.”
Joining the Colorado School of Medicine only strengthened his belief that teaching hospitals can provide excellent care.
At the American Association for thoracic surgery conference in 2010, he presented on the topic “Should esophagectomies only be performed by thoracic surgeons?” He was also part of an examination that included long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer. He compared never smokers to current smokers.
He graduated from Brown University Medical School in 2002, following an undergraduate degree also at Brown. At Johns Hopkins, he received the G. Melville Williams Hero Award for outstanding service.
Disclaimer: Dr. Robert Meguid has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More